PRESELECT: Preoperative Self-assessment for Cardio-pulmonary Risk Stratification

Sponsor
Universitätsklinikum Hamburg-Eppendorf (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04156594
Collaborator
(none)
5,500
1
36.9
149.1

Study Details

Study Description

Brief Summary

This prospective study intends to development and validation a patient self-assessment questionnaire. The aim of the self-assessment, by questionnaire, is to estimate the risk of postoperative pulmonary complications (PPC).

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    PPC are common adverse events operative patients. Existing concepts of pulmonary risk evaluation are based on complex risk scores, preoperative apparatus examinations, laboratory parameters and medical findings. The significance of apparatus diagnostics for the preoperative Pulmonary risk evaluation is highly controversial and guidelines recommend a reluctant use. A large prospective study (PREDICT, unpublished to date, NCT02566343) showed that lung function assessment in patients with COPD symptoms undergoing major non-cardiac surgery did not improve the anamnestic risk assessment. In a large study it could be shown that a subjective self-assessment of physical performance by means of a structured questionnaire (DASI), in contrast to a subjective medical assessment, suitable for predicting perioperative cardiac events. Our unpublished data show that a subjective self-assessment of "limited exercise capacity" in patients with COPD is predictive of PPC is suitable.

    Objectives:
    • Development of a self-assessment questionnaire as part of a Delphi trial

    • Validation of the self-assessment questionnaire

    Methodology:

    Prospective observational, case control study of 5000 patients undergoing surgery in general anesthesia (estimated enrollment of 5500 patients with a dropout rate of approximately 10%).

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Preoperative Self-assessment for Cardio-pulmonary Risk Stratification
    Actual Study Start Date :
    Nov 4, 2019
    Actual Primary Completion Date :
    Feb 11, 2022
    Anticipated Study Completion Date :
    Dec 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative pulmonary complications (PPC) [until hospital discharge up to 6 months after surgery]

      European Perioperative Clinical Outcome (EPCO) definitions

    Secondary Outcome Measures

    1. Major Adverse Cardiac Events (MACE) [until hospital discharge up to 6 months after surgery]

      European Perioperative Clinical Outcome (EPCO) definitions

    2. New diagnoses in the context of the current hospital stay New pulmonary or cardiac diagnoses [until hospital discharge up to 6 months after surgery]

      New diagnoses in the context of the current hospital stay New pulmonary or cardiac diagnoses

    3. Duration of hospitalization (days) [until hospital discharge up to 6 months after surgery]

      Duration of hospitalization (days)

    4. in-hospital mortality [until hospital discharge up to 6 months after surgery]

      in-hospital mortality

    5. Length of stay in the intensive care unit (days) [until hospital discharge up to 6 months after surgery]

      Length of stay in the intensive care unit (days)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years and older

    • Operations in general anesthesia

    Exclusion Criteria:
    • < 18 Years

    • Pregnancy

    • Lack of cooperation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Medical Center Hamburg-Eppendorf Hamburg Germany 20246

    Sponsors and Collaborators

    • Universitätsklinikum Hamburg-Eppendorf

    Investigators

    • Principal Investigator: André Dankert, MD, Universitätsklinikum Hamburg-Eppendorf

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    André Dankert, MD, Principal Investigator, Universitätsklinikum Hamburg-Eppendorf
    ClinicalTrials.gov Identifier:
    NCT04156594
    Other Study ID Numbers:
    • PV7061
    First Posted:
    Nov 7, 2019
    Last Update Posted:
    Mar 2, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by André Dankert, MD, Principal Investigator, Universitätsklinikum Hamburg-Eppendorf
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 2, 2022